- Home
- KUKE vs LEXX Comparison
KUKE vs LEXX Comparison
Compare KUKE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KUKE
- LEXX
- Stock Information
- Founded
- KUKE 2002
- LEXX 2004
- Country
- KUKE China
- LEXX Canada
- Employees
- KUKE N/A
- LEXX N/A
- Industry
- KUKE Other Consumer Services
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- KUKE Real Estate
- LEXX Health Care
- Exchange
- KUKE Nasdaq
- LEXX Nasdaq
- Market Cap
- KUKE 49.8M
- LEXX 49.3M
- IPO Year
- KUKE 2021
- LEXX N/A
- Fundamental
- Price
- KUKE $0.72
- LEXX $3.01
- Analyst Decision
- KUKE
- LEXX Strong Buy
- Analyst Count
- KUKE 0
- LEXX 2
- Target Price
- KUKE N/A
- LEXX $11.00
- AVG Volume (30 Days)
- KUKE 217.2K
- LEXX 94.0K
- Earning Date
- KUKE 10-22-2024
- LEXX 11-18-2024
- Dividend Yield
- KUKE N/A
- LEXX N/A
- EPS Growth
- KUKE N/A
- LEXX N/A
- EPS
- KUKE N/A
- LEXX N/A
- Revenue
- KUKE $15,080,878.00
- LEXX $411,019.00
- Revenue This Year
- KUKE N/A
- LEXX $82.02
- Revenue Next Year
- KUKE N/A
- LEXX $95.09
- P/E Ratio
- KUKE N/A
- LEXX N/A
- Revenue Growth
- KUKE N/A
- LEXX 34.05
- 52 Week Low
- KUKE $0.48
- LEXX $0.90
- 52 Week High
- KUKE $4.07
- LEXX $6.85
- Technical
- Relative Strength Index (RSI)
- KUKE 48.09
- LEXX 41.43
- Support Level
- KUKE $0.70
- LEXX $2.91
- Resistance Level
- KUKE $0.78
- LEXX $3.39
- Average True Range (ATR)
- KUKE 0.09
- LEXX 0.20
- MACD
- KUKE 0.03
- LEXX -0.02
- Stochastic Oscillator
- KUKE 78.73
- LEXX 13.49
About KUKE Kuke Music Holding Limited each representing one
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.